Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: A review

Table 2 Age, sex and American Society of Anesthesiologist physical status classification system of patients in the included papers, number of patients with colorectal liver metastases and chemotherapy

Ref.	Age (median and range)	Sex	ASA	Number of patients with CRLM	Neoadjuvant chemotherapy
Schnitzbauer et al[20]	63 (32-75)	14 M, 11 F		14	11 CRLM (7 folfox, 1 folfox + cetuximab, 1 folfox + bevacizumab, 1 xeliri + cetuximab, 1 xelox), 1 gastric cancer (flot3)
Torres et al[37]	57.3 (20-83)	22 M, 17 F		7	Not specified
Oldhafer et al[25]	65 (52-81)	4 M, 3 F			2 (folfox + bevacizumab, folfiri + bevacizumab/HD-5FU)
Ratti et al[24]	61 (45-72)	6 M, 2 F	7 ASA 2, 1 ASA 3	5	5 CRLM (folfiri + bevacizumab, folfox + bevacizumab, folfiri + cetuximab, folfiri, folfox + cetuximab)
Nadalin et al[21]	67 (43-80)	7 M, 8 F	10 ASA 2, 3 ASA 5	5	5 CRLM (4 folfox, 1 folfiri)
Ielpo et al[38]	58.5 (56-63)	2 M, 4 F		5	5 CRLM, regimen not specified
Schadde et al[39]	57 (48.5-65)	29 M, 19 F	40 ASA 1-2, 8 > 2	26	28, diagnosis and regimen not specified
Gauzolino et al[40]	52.5 (49-67)	3 M, 1 F		4	2 oxaliplation, 2 irinotecan
Troja et al[41]	65 (38-72)	4 M, 1 F		2	1 CRLM (folfiri + bevacizumab), 1 (imatinib/sunitinib, 1 cisplatin/5-FU)

CRLM: Colorectal liver metastases; CCA: Cholangiocarcinoma; HCC: Hepatocellular carcinoma; GIST: Gastrointestinal stromal tumor; ASA: American Society of Anesthesiologist physical status classification system; M: Male; F: Female.